| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Proceeds from short term debt | - | - | - | 0 |
| Repayment of short term debt | - | - | - | 0 |
| Other financing activities | 1 | 3 | 3 | -19 |
| Net cash provided by (used in) financing activities | -2,191 | -1,738 | -1,744 | -1,117 |
| Translation adjustment on cash and cash equivalents | 31 | 40 | 45 | -53 |
| Net change in cash and cash equivalents | -1,097 | -1,139 | -1,603 | 92 |
| Cash and cash equivalents at beginning of period | 3,300 | 3,300 | 3,300 | 3,227 |
| Cash and cash equivalents at end of period | 2,203 | 2,161 | 1,697 | 3,319 |
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVJF)